SLBT earnings date and last-quarter result: P/E 0.00. Updated 2026-07-23.
SL Science Holding (SLBT) Research Hub
SL Science Holding (SLBT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.23 USD (+6.96%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 0.00, market cap 0.03B. This hub links to the full technical, earnings and options research available for SLBT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.23 USD (+6.96%) |
| 52-week range | 1.02 USD – 6.99 USD |
| Trend regime | Range |
| 14-day RSI | 23.6 (Oversold) |
| Trailing P/E | 0.00 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
Available research for SLBT
Covered Call on SLBT: how it works, illustrative setup around the real 1.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SLBT: how it works, illustrative setup around the real 1.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SLBT: how it works, illustrative setup around the real 1.23 USD price, max profit/loss, breakeven and when to use it. Educational.
SLBT technical analysis: range, last 1.23 USD, RSI 23.6, 52w range 1.02 USD–6.99 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SLBT in?
SL Science Holding (SLBT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SLBT in an uptrend or downtrend?
As of 2026-10-26, SLBT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SLBT's trailing P/E ratio?
SLBT's trailing P/E is 0.00, with a market cap of 0.03B. See the earnings research page for full valuation detail.